Entrada Therapeutics, Inc. TRDA

Set alert

4.72 USD -0.39 (-7.63%)

At closeNov 3, 2026, 4:01 PM EST

4.72 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

4.62 Day range 5.08

4.11 52-week range 16.45

Held by insiders 12.77%

Held by institutions 80.85%

Float held by institutions 92.69%

Institutions 150

Top institutional holders
Holder	% held	Shares	Value	Reported
Baker Bros. Advisors, LP	13.00%	4,865,819	84.96M	Sep 29, 2024
MPM Asset Management, LLC	11.83%	4,425,784	77.27M	Sep 29, 2024
5AM Venture Management, LLC	11.78%	4,408,379	76.97M	Sep 29, 2024
Price (T.Rowe) Associates Inc	8.15%	3,049,572	53.25M	Sep 29, 2024
Blackrock Inc.	4.87%	1,822,835	31.83M	Sep 29, 2024
FMR, LLC	4.66%	1,743,498	30.44M	Sep 29, 2024

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Price (T.Rowe) New Horizons Fund	5.19%	1,942,377	33.91M	Sep 29, 2024
Vanguard Total Stock Market Index Fund	1.81%	677,414	11.83M	Sep 29, 2024
iShares Russell 2000 ETF	1.70%	634,828	11.08M	Oct 30, 2024
Price (T.Rowe) New Horizons Trust	1.20%	449,109	7.84M	Sep 29, 2024
Fidelity Growth Company Fund	0.96%	357,801	6.25M	Oct 30, 2024
Fidelity Select Portfolios - Biotechnology	0.83%	309,169	5.40M	Oct 30, 2024

TRDA insiders
Insider	Relation	Latest transaction	Date	Shares held
DOSHI DIPAL	Chief Executive Officer	Sale	Jul 14, 2024	334,475
DOWDEN NATHAN J	President	Sale	Sep 25, 2024	125,149
KIM PETER S	Director	Conversion of Exercise of derivative security	Jun 2, 2024	104,330
KREHER NERISSA C	Officer	Sale	Sep 5, 2023	40,037
SETHURAMAN NATARAJAN	Officer	Sale	Dec 2, 2024	144,997
WENTWORTH KORY JAMES	Chief Financial Officer	Conversion of Exercise of derivative security	Dec 1, 2024	73,849

Held by funds